Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

January 31, 2006

Conditions

Acute Myelogenous Leukemia

Interventions

BIOLOGICAL

GVAX leukemia vaccine (therapeutic cellular vaccine, GM-CSF producing)

Trial Locations (4)

Johns Hopkins University, Baltimore

University of Chicago, Chicago

University of California, San Francisco, San Francisco

Dana Farber Cancer Institute, Boston